Connecting you to content on EBSCOhost

Works matching AU Walenkamp, Annemiek M.E.

Results: 4

1

<sup>89</sup>Zr-Bevacizumab PET Visualizes Disease Manifestations in Patients with von Hippel-Lindau Disease.

Published in:

Journal of Nuclear Medicine, 2016, v. 57, n. 8, p. 1244, doi. 10.2967/jnumed.115.167643

By:

Oosting, Sjoukje F.;
van Asselt, Sophie J.;
Brouwers, Adrienne H.;
Bongaerts, Alfons H.H.;
Steinberg, Julia D.J.;
de Jong, Johan R.;
Lub-de Hooge, Marjolijn N.;
van der Horst-Schrivers, Anouk N.A.;
Walenkamp, Annemiek M.E.;
Hoving, Eelco W.;
Sluiter, Wim J.;
Zonnenberg, Bernard A.;
de Vries, Elisabeth G.E.;
Links, Thera P.

Publication type:

Article

2

Niacin (Vitamin B<sub>3</sub>) Supplementation in Patients with Serotonin-Producing Neuroendocrine Tumor.

Published in:

Neuroendocrinology, 2016, v. 103, n. 5, p. 489, doi. 10.1159/000440621

By:

Bouma, Grietje;
van Faassen, Martijn;
Kats-Ugurlu, Gursah;
de Vries, Elisabeth G.E.;
Kema, Ido P.;
Walenkamp, annemiek M.E.

Publication type:

Article

3

At the Bedside: Profiling and treating patients with CXCR4‐expressing cancers.

Published in:

Journal of Leukocyte Biology, 2021, v. 109, n. 5, p. 953, doi. 10.1002/JLB.5BT1219-714R

By:

Martin, Miguel;
Mayer, Ingrid A.;
Walenkamp, Annemiek M.E.;
Lapa, Constantin;
Andreeff, Michael;
Bobirca, Alexandra

Publication type:

Article

4

The Current Status of Immune Checkpoint Inhibitors in Neuro-Oncology: A Systematic Review.

Published in:

Cancers, 2020, v. 12, n. 3, p. 586, doi. 10.3390/cancers12030586

By:

Brahm, Cyrillo G.;
van Linde, Myra E.;
Enting, Roelien H.;
Schuur, Maaike;
Otten, René H.J.;
Heymans, Martijn W.;
Verheul, Henk M.W.;
Walenkamp, Annemiek M.E.

Publication type:

Article